HSIE Results Daily: Max Healthcare Institute, Mankind Pharma, J Kumar Infraprojects
Max Healthcare Institute: EBITDA^ grew 28% YoY, with 29% YoY sales growth (hospital sales up 29%, acquired/new unit sales at INR 3.9 bn, and Max...
187 Views
APAC Healthcare Weekly (May 18)-Hengrui Medicine, Wuxi Biologics, Chugai, GC Biopharma, Mayne Pharma
Jiangsu Hengrui launches HK IPO. Wuxi Biologics to sell Germany plant. Chugai got Japan approval for gene therapy. Mayne Pharma was hit as FDA...
589 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
163 Views
Quiddity Leaderboard NIFTY Sep25: US$1bn+ Total One-Way Flows; ADDs Strongly Outperforming DELs
Collectively, we see total one-way flows of more than US$1bn for NIFTY 50 and NIFTY Next 50 in September 2025. The NIFTY 50 expected changes have...
623 Views
Pharmaceuticals: Pharma dodges first round of US tariff risk
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India
213 Views